Lipid changes due to fenofibrate treatment are not associated with changes in DNA methylation patterns in the GOLDN study

Fenofibrate lowers triglycerides (TG) and raises high density lipoprotein cholesterol (HDLc) in dyslipidemic individuals. Several studies have shown genetic variability in lipid responses to fenofibrate treatment. It is, however, not known whether epigenetic patterns are also correlated with the cha...

Descripció completa

Dades bibliogràfiques

Autors principals:	Mithun eDas, Ryan eIrvin, Jin eSha, Stella eAslibekyan, Bertha eHidalgo, Rodney T Perry, Degui eZhi, Hemant K Tiwari, Devin eAbsher, Jose M Ordovas, Donna K Arnett
Format:	Artigo
Idioma:	Inglês
Publicat:	Frontiers Media S.A. 2015-09-01
Col·lecció:	Frontiers in Genetics
Matèries:	DNA Methylation Fenofibrate cardiovascular disease Dyslipidemia Epigenetic changes Lipid lowering drug
Accés en línia:	http://journal.frontiersin.org/Journal/10.3389/fgene.2015.00304/full
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!